Abstract: The subject matter of the present disclosure generally relates to techniques for following a treatment protocol having one or more treatment parameters to cause a targeted physiological outcome at a distal site, assessing an expression level of a gene in a region of interest after completing the treatment protocol, and modifying the one or more treatment parameters based on the expression level of the gene. The treatment protocol may include one or more ultrasound energy treatments to the region of interest.
Description:ENCLOSED , Claims:ENCLOSED
| # | Name | Date |
|---|---|---|
| 1 | 202318042081-STATEMENT OF UNDERTAKING (FORM 3) [23-06-2023(online)].pdf | 2023-06-23 |
| 2 | 202318042081-REQUEST FOR EXAMINATION (FORM-18) [23-06-2023(online)].pdf | 2023-06-23 |
| 3 | 202318042081-PRIORITY DOCUMENTS [23-06-2023(online)].pdf | 2023-06-23 |
| 4 | 202318042081-FORM 18 [23-06-2023(online)].pdf | 2023-06-23 |
| 5 | 202318042081-FORM 1 [23-06-2023(online)].pdf | 2023-06-23 |
| 6 | 202318042081-FIGURE OF ABSTRACT [23-06-2023(online)].pdf | 2023-06-23 |
| 7 | 202318042081-DRAWINGS [23-06-2023(online)].pdf | 2023-06-23 |
| 8 | 202318042081-DECLARATION OF INVENTORSHIP (FORM 5) [23-06-2023(online)].pdf | 2023-06-23 |
| 9 | 202318042081-COMPLETE SPECIFICATION [23-06-2023(online)].pdf | 2023-06-23 |
| 10 | 202318042081-FORM-26 [26-06-2023(online)].pdf | 2023-06-26 |
| 11 | 202318042081-Proof of Right [13-10-2023(online)].pdf | 2023-10-13 |